No Data
No Data
Black Diamond Theraptcs Is Maintained at Buy by Stifel
Wedbush Adjusts Black Diamond Therapeutics Price Target to $11 From $16, Maintains Outperform Rating
Express News | Black Diamond Therapeutics Inc : Stifel Cuts Target Price to $15 From $16
Analysts Offer Insights on Healthcare Companies: Ventyx Biosciences (VTYX), Black Diamond Therapeutics (BDTX) and Passage Bio (PASG)
Black Diamond Reports Strong Fourth Quarter and Year-End Results and Declares Dividend
Black Diamond Theraptcs Cash, Cash Equivalents, and Investments of $98.6 M as of Dec 31, Expected to Be Sufficient to Fund Ops Into Q4 2026
Newbee4 : $Bridger Aerospace (BAER.US)$